2024 Q2 Form 10-Q Financial Statement

#000073101224000065 Filed on April 26, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $426.3M $423.4M
YoY Change 1.76% 1.49%
Cost Of Revenue $384.7M $358.7M
YoY Change 4.63% -0.63%
Gross Profit $41.55M $64.72M
YoY Change -18.86% 15.06%
Gross Profit Margin 9.75% 15.29%
Selling, General & Admin $44.44M $51.01M
YoY Change 7.26% 27.38%
% of Gross Profit 106.96% 78.82%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.000M $3.531M
YoY Change -16.55% -5.08%
% of Gross Profit 7.22% 5.46%
Operating Expenses $44.44M $51.01M
YoY Change 7.26% 27.38%
Operating Profit -$2.891M $13.71M
YoY Change -129.58% -15.39%
Interest Expense -$1.716M $1.904M
YoY Change -204.91% -208.74%
% of Operating Profit 13.89%
Other Income/Expense, Net $905.0K $5.699M
YoY Change
Pretax Income -$1.986M $21.31M
YoY Change -117.41% 21.41%
Income Tax -$198.0K $6.005M
% Of Pretax Income 28.17%
Net Earnings -$1.788M $15.31M
YoY Change -120.8% 20.7%
Net Earnings / Revenue -0.42% 3.62%
Basic Earnings Per Share -$0.02 $0.21
Diluted Earnings Per Share -$0.02 $0.21
COMMON SHARES
Basic Shares Outstanding 73.65M shares 73.58M shares
Diluted Shares Outstanding 73.85M shares 74.06M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $105.7M $104.9M
YoY Change -13.23% -6.45%
Cash & Equivalents $26.43M $29.29M
Short-Term Investments $79.30M $75.62M
Other Short-Term Assets $68.60M $50.33M
YoY Change 161.06% 99.8%
Inventory $17.86M $18.04M
Prepaid Expenses $25.77M $25.63M
Receivables $398.9M $407.1M
Other Receivables $0.00 $0.00
Total Short-Term Assets $573.2M $580.4M
YoY Change 4.39% 13.79%
LONG-TERM ASSETS
Property, Plant & Equipment $29.84M $29.19M
YoY Change 10.8% 24.74%
Goodwill $75.53M $75.53M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.505M $84.00M
YoY Change -93.17% 10953.16%
Total Long-Term Assets $226.5M $223.5M
YoY Change 6.5% 6.9%
TOTAL ASSETS
Total Short-Term Assets $573.2M $580.4M
Total Long-Term Assets $226.5M $223.5M
Total Assets $799.7M $803.9M
YoY Change 4.98% 11.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $72.22M $72.92M
YoY Change 10.05% 13.31%
Accrued Expenses $21.59M $83.41M
YoY Change -73.42% 35.72%
Deferred Revenue
YoY Change
Short-Term Debt $30.00M $40.00M
YoY Change -25.0% 14.29%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $209.5M $209.4M
YoY Change 10.45% 29.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $724.0K $119.9M
YoY Change -99.4% 1759.86%
Total Long-Term Liabilities $724.0K $119.9M
YoY Change -99.4% 1759.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $209.5M $209.4M
Total Long-Term Liabilities $724.0K $119.9M
Total Liabilities $210.2M $329.3M
YoY Change -32.45% 95.3%
SHAREHOLDERS EQUITY
Retained Earnings $198.6M $200.4M
YoY Change 12.97% 19.85%
Common Stock $314.9M $312.8M
YoY Change 2.71% 2.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $471.4M $474.6M
YoY Change
Total Liabilities & Shareholders Equity $799.7M $803.9M
YoY Change 4.98% 11.78%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$1.788M $15.31M
YoY Change -120.8% 20.7%
Depreciation, Depletion And Amortization $3.000M $3.531M
YoY Change -16.55% -5.08%
Cash From Operating Activities $16.32M -$26.03M
YoY Change 120.44% 59.81%
INVESTING ACTIVITIES
Capital Expenditures $1.312M $2.198M
YoY Change 20.7% 117.62%
Acquisitions
YoY Change
Other Investing Activities -$26.44M $13.91M
YoY Change -2316.51% 5111.24%
Cash From Investing Activities -$27.76M $11.72M
YoY Change -26283.96% -1676.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -13.00M 13.97M
YoY Change -360.0% 102.26%
NET CHANGE
Cash From Operating Activities 16.32M -26.03M
Cash From Investing Activities -27.76M 11.72M
Cash From Financing Activities -13.00M 13.97M
Net Change In Cash -24.44M -347.0K
YoY Change -295.35% -96.57%
FREE CASH FLOW
Cash From Operating Activities $16.32M -$26.03M
Capital Expenditures $1.312M $2.198M
Free Cash Flow $15.01M -$28.23M
YoY Change 137.6% 63.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25631000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
22247000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
580414000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
571696000 usd
CY2024Q1 hcsg Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
29190000 usd
CY2023Q4 hcsg Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
28774000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
75529000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
75529000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
37228000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
36557000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11456000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12127000 usd
CY2024Q1 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
3720000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
72916000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
83224000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
38338000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
56142000 usd
CY2023Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
7201000 usd
CY2024Q1 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
1293000 usd
CY2023Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
1501000 usd
CY2024Q1 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
23138000 usd
CY2023Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
22681000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
209375000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
216928000 usd
CY2024Q1 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
62796000 usd
CY2023Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
61697000 usd
CY2024Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
44271000 usd
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
41186000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
37749000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
474581000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
456616000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
803880000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
790652000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
423433000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
417230000 usd
CY2023Q4 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
4449000 usd
CY2024Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
23287000 usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
24832000 usd
CY2024Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
44269000 usd
CY2023Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
40812000 usd
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
35434000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
35226000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4301000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1656000 usd
CY2024Q1 us-gaap Assets
Assets
803880000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
21931000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
21179000 usd
CY2024Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
40000000 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
25000000 usd
CY2024Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
11759000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10590000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11235000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2267000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2990000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76533000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76329000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73646000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73341000 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
765000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
763000 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
312080000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
310436000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
200381000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
185010000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2172000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1844000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2887000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2988000 shares
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
36473000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://hcsgcorp.com/20240331#PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://hcsgcorp.com/20240331#PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
91868000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
87250000 usd
CY2024Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
407140000 usd
CY2023Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
383509000 usd
CY2024Q1 us-gaap Other Inventory
OtherInventory
18042000 usd
CY2023Q4 us-gaap Other Inventory
OtherInventory
18479000 usd
CY2023Q4 us-gaap Assets
Assets
790652000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
358911000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
362379000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
46911000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
40047000 usd
CY2024Q1 hcsg Investment Income And Other
InvestmentIncomeAndOther
5699000 usd
CY2023Q1 hcsg Investment Income And Other
InvestmentIncomeAndOther
3102000 usd
CY2024Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1996000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1751000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
21314000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16155000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6005000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4484000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
15309000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
11671000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73926000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74497000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74055000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74518000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
15309000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
11671000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-328000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1207000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14981000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12878000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3531000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3720000 usd
CY2024Q1 hcsg Accounts And Financing Receivable Credit Loss Expense Reversal
AccountsAndFinancingReceivableCreditLossExpenseReversal
4921000 usd
CY2023Q1 hcsg Accounts And Financing Receivable Credit Loss Expense Reversal
AccountsAndFinancingReceivableCreditLossExpenseReversal
6907000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-121000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
43000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2484000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2058000 usd
CY2024Q1 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
459000 usd
CY2023Q1 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
533000 usd
CY2024Q1 hcsg Unrealized Gain Loss On Securities Related To Deferred Compensation Fund
UnrealizedGainLossOnSecuritiesRelatedToDeferredCompensationFund
4110000 usd
CY2023Q1 hcsg Unrealized Gain Loss On Securities Related To Deferred Compensation Fund
UnrealizedGainLossOnSecuritiesRelatedToDeferredCompensationFund
1502000 usd
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1308000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
336000 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-180000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-128000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
27007000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
20633000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-438000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-935000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3350000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4076000 usd
CY2024Q1 hcsg Increase Decrease In Deferred Compensation Funding
IncreaseDecreaseInDeferredCompensationFunding
-653000 usd
CY2023Q1 hcsg Increase Decrease In Deferred Compensation Funding
IncreaseDecreaseInDeferredCompensationFunding
-683000 usd
CY2024Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-13493000 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-6422000 usd
CY2024Q1 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-16815000 usd
CY2023Q1 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-19766000 usd
CY2024Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
2070000 usd
CY2023Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
2136000 usd
CY2024Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
1556000 usd
CY2023Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
2366000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
3394000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
713000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26033000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16290000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
25000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
57000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2198000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1010000 usd
CY2024Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
2750000 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 usd
CY2024Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
16639000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
210000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11716000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-743000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2223000 usd
CY2024Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
15000000 usd
CY2023Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
10000000 usd
CY2024Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
1030000 usd
CY2023Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
870000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13970000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6907000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-347000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10126000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54330000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26279000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53983000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16153000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
456616000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
15309000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-328000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1030000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2444000 usd
CY2024Q1 hcsg Stock Issued During Period Value Treasury Stock Reissued Deferred Compensation Net
StockIssuedDuringPeriodValueTreasuryStockReissuedDeferredCompensationNet
519000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
989000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
62000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
474581000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
418279000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
11671000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1207000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-870000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1973000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2223000 usd
CY2024Q1 hcsg Revenue From Contract With Customer Renewal Term
RevenueFromContractWithCustomerRenewalTerm
P1Y
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing financial statements in conformity with U.S. GAAP, estimates and assumptions are made that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results could differ from those estimates. Significant estimates are used in determining, but are not limited to, the Company’s allowance for doubtful accounts, accrued insurance claims, deferred taxes and reviews for potential impairment. The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information. Management regularly evaluates this information to determine if it is necessary to update the basis for its estimates and to adjust for known changes.</span></div>
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29288000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16153000 usd
CY2024Q1 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
24695000 usd
CY2023Q1 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
0 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53983000 usd
CY2024Q1 us-gaap Contract With Customer Timing Of Satisfaction Of Performance Obligation And Payment
ContractWithCustomerTimingOfSatisfactionOfPerformanceObligationAndPayment
The Company’s payment terms with customers on promissory notes can vary based on several factors and the circumstances of each promissory note, however most promissory notes mature over 1 to 4 years. Similar to accounts receivable, each reporting period the Company evaluates the collectability of outstanding notes receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit losses
CY2024Q1 hcsg Period Of Amortization Of Inventories And Supplies
PeriodOfAmortizationOfInventoriesAndSupplies
P24M
CY2023Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2024Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial instruments that are subject to credit risk are cash and cash equivalents, restricted cash equivalents, marketable securities, deferred compensation funding and accounts and notes receivable. At March 31, 2024, the majority of the Company’s cash and cash equivalents, restricted cash equivalents and marketable securities were held in two large financial institutions located in the United States. At December 31, 2023, the majority were held in one large financial institution located in the United States. The Company’s marketable securities are fixed income investments which are highly liquid and can be readily purchased or sold through established markets. The Company’s deferred compensation funding consists of fund and money market investments all of which are highly liquid and held in a trust account.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s customers are concentrated in the healthcare industry and are primarily providers of long-term care. The revenues of many of the Company’s customers are highly reliant on Medicare, Medicaid and third party payors’ reimbursement funding rates. New legislation or changes in existing regulations could directly impact the governmental reimbursement programs in which the Company’s customers participate. As a result, the Company may not realize the full effects such programs may have on the Company’s customers until such new legislation or changes in existing regulations are fully implemented and governmental agencies issue applicable regulations or guidance.</span></div>
CY2024Q1 hcsg Concentration Risk Numberof Financial Institutions Holding Cashand Cash Equivalentsand Marketable Securities
ConcentrationRiskNumberofFinancialInstitutionsHoldingCashandCashEquivalentsandMarketableSecurities
2 institution
CY2023Q4 hcsg Concentration Risk Numberof Financial Institutions Holding Cashand Cash Equivalentsand Marketable Securities
ConcentrationRiskNumberofFinancialInstitutionsHoldingCashandCashEquivalentsandMarketableSecurities
1 institution
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period line items in the Consolidated Statements of Stockholders’ Equity have been revised to conform with current period presentation.</span></div>
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
362379000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16155000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4484000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
11671000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2024Q1 hcsg Revenue From Contract With Customer Renewal Term
RevenueFromContractWithCustomerRenewalTerm
P1Y
CY2024Q1 us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
The Company’s contracts with customers typically provide for an initial term of one year, with renewable one year service terms, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days.
CY2024Q1 hcsg Revenue From Contract With Customer Initial Term
RevenueFromContractWithCustomerInitialTerm
P1Y
CY2024Q1 hcsg Revenue From Contract With Customer Renewal Term
RevenueFromContractWithCustomerRenewalTerm
P1Y
CY2024Q1 hcsg Accounts Notes Loansand Financing Receivable Gross Current
AccountsNotesLoansandFinancingReceivableGrossCurrent
499008000 usd
CY2023Q4 hcsg Accounts Notes Loansand Financing Receivable Gross Current
AccountsNotesLoansandFinancingReceivableGrossCurrent
470759000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
91868000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
87250000 usd
CY2024Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
407140000 usd
CY2023Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
383509000 usd
CY2024Q1 us-gaap Notes And Loans Receivable Gross Noncurrent
NotesAndLoansReceivableGrossNoncurrent
27007000 usd
CY2023Q4 us-gaap Notes And Loans Receivable Gross Noncurrent
NotesAndLoansReceivableGrossNoncurrent
29281000 usd
CY2024Q1 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
3720000 usd
CY2023Q4 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
4449000 usd
CY2024Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
23287000 usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
24832000 usd
CY2024Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
430427000 usd
CY2023Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
408341000 usd
CY2024Q1 us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
1100000 usd
CY2023Q1 us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
600000 usd
CY2024Q1 hcsg Financing Receivable Allowance For Credit Loss Writeoff Year One Originated Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffYearOneOriginatedCurrentFiscalYear
0 usd
CY2024Q1 hcsg Financing Receivable Allowance For Credit Loss Writeoff Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
0 usd
CY2024Q1 hcsg Financing Receivable Allowance For Credit Loss Writeoff Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
0 usd
CY2024Q1 hcsg Financing Receivable Allowance For Credit Loss Writeoff Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
0 usd
CY2024Q1 hcsg Financing Receivable Allowance For Credit Loss Writeoff Year Five Originated Four Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
0 usd
CY2024Q1 hcsg Financing Receivable Allowance For Credit Loss Writeoff Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
0 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
0 usd
CY2024Q1 hcsg Financing Receivable Allowance For Credit Loss Recovery Year One Originated Current Fiscal Year
FinancingReceivableAllowanceForCreditLossRecoveryYearOneOriginatedCurrentFiscalYear
0 usd
CY2024Q1 hcsg Financing Receivable Allowance For Credit Loss Recovery Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossRecoveryYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
0 usd
CY2024Q1 hcsg Financing Receivable Allowance For Credit Loss Recovery Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossRecoveryYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
0 usd
CY2024Q1 hcsg Financing Receivable Allowance For Credit Loss Recovery Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossRecoveryYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
0 usd
CY2024Q1 hcsg Financing Receivable Allowance For Credit Loss Recovery Year Five Originated Four Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossRecoveryYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
0 usd
CY2024Q1 hcsg Financing Receivable Allowance For Credit Loss Recovery Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossRecoveryOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
0 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
0 usd
CY2024Q1 hcsg Financing Receivable Allowance For Credit Loss Writeoff After Recovery Year One Originated Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecoveryYearOneOriginatedCurrentFiscalYear
0 usd
CY2024Q1 hcsg Financing Receivable Allowance For Credit Loss Writeoff After Recovery Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecoveryYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
0 usd
CY2024Q1 hcsg Financing Receivable Allowance For Credit Loss Writeoff After Recovery Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecoveryYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
0 usd
CY2024Q1 hcsg Financing Receivable Allowance For Credit Loss Writeoff After Recovery Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecoveryYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
0 usd
CY2024Q1 hcsg Financing Receivable Allowance For Credit Loss Writeoff After Recovery Year Five Originated Four Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecoveryYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
0 usd
CY2024Q1 hcsg Financing Receivable Allowance For Credit Loss Writeoff After Recovery Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecoveryOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
0 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery
0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
80819000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1033000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4301000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
84087000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10880000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery
0 usd
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
620000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
11500000 usd
CY2023Q4 us-gaap Accounts And Financing Receivable Allowance For Credit Loss
AccountsAndFinancingReceivableAllowanceForCreditLoss
91699000 usd
CY2024Q1 hcsg Accounts And Financing Receivable Allowance For Credit Loss Writeoff
AccountsAndFinancingReceivableAllowanceForCreditLossWriteoff
1033000 usd
CY2024Q1 hcsg Accounts And Financing Receivable Credit Loss Expense Reversal
AccountsAndFinancingReceivableCreditLossExpenseReversal
4921000 usd
CY2024Q1 us-gaap Accounts And Financing Receivable Allowance For Credit Loss
AccountsAndFinancingReceivableAllowanceForCreditLoss
95587000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
100000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
66601000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
3453000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5259000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
68407000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6863000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery
51000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1648000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8460000 usd
CY2022Q4 us-gaap Accounts And Financing Receivable Allowance For Credit Loss
AccountsAndFinancingReceivableAllowanceForCreditLoss
73464000 usd
CY2023Q1 hcsg Accounts And Financing Receivable Allowance For Credit Loss Writeoff
AccountsAndFinancingReceivableAllowanceForCreditLossWriteoff
3504000 usd
CY2023Q1 hcsg Accounts And Financing Receivable Credit Loss Expense Reversal
AccountsAndFinancingReceivableCreditLossExpenseReversal
6907000 usd
CY2023Q1 us-gaap Accounts And Financing Receivable Allowance For Credit Loss
AccountsAndFinancingReceivableAllowanceForCreditLoss
76867000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
100000 usd
CY2024Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-495000 usd
CY2023Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
1206000 usd
CY2024Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-167000 usd
CY2023Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-1000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-328000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1207000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
200000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
100000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-100000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
300000 usd
CY2024Q1 hcsg Operating Lease Right Of Use Asset Before Accumulated Amortization
OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization
28005000 usd
CY2023Q4 hcsg Operating Lease Right Of Use Asset Before Accumulated Amortization
OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization
27099000 usd
CY2024Q1 hcsg Property Plant And Equipment And Operating Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
52745000 usd
CY2023Q4 hcsg Property Plant And Equipment And Operating Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
50803000 usd
CY2024Q1 hcsg Property Plant And Equipment And Operating Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
23555000 usd
CY2023Q4 hcsg Property Plant And Equipment And Operating Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
22029000 usd
CY2024Q1 hcsg Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
29190000 usd
CY2023Q4 hcsg Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
28774000 usd
CY2024Q1 hcsg Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
10400000 usd
CY2023Q4 hcsg Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
9400000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
2900000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
2500000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1800000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1200000 usd
CY2024Q1 hcsg Lessee Operating Lease Termination Option Term
LesseeOperatingLeaseTerminationOptionTerm
P1Y
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1837000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1387000 usd
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
171000 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
232000 usd
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
290000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
450000 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
2298000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
2069000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1911000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1514000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y1M6D
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.067
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.051
CY2024Q1 hcsg Right Of Use Asset And Operating Lease Liability Decrease Due To Cancellation
RightOfUseAssetAndOperatingLeaseLiabilityDecreaseDueToCancellation
100000 usd
CY2023Q1 hcsg Right Of Use Asset And Operating Lease Liability Decrease Due To Cancellation
RightOfUseAssetAndOperatingLeaseLiabilityDecreaseDueToCancellation
700000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
5769000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7080000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4252000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1469000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1389000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
116000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
20075000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1918000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
18157000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2014000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2685000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2666000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1196000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
613000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
508000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1774000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-300000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1200000 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-700000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
300000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
16600000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
200000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
200000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
100000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
4100000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
1500000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
78368000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
204000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2954000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
75618000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
95466000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
387000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2722000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
93131000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1025000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
6324000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
25371000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
34939000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
37006000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
39309000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
12216000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
12559000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
75618000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
93131000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2484000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2058000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2484000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2058000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
24800000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y3M18D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2438000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
30.43
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
290000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.36
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
172000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
28.13
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2556000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
28.31
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.06
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.53
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.039
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.040
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y10M24D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.405
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.395
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
614000 usd
CY2024Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P5Y2M12D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1763000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
33.94
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y3M18D
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
40000000 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1000000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
900000 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2689000 shares
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
423433000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
417230000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
21314000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16155000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
15309000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
11671000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73926000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74497000 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
129000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
21000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74055000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74518000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3191000 shares
CY2024Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
300000000 usd
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
25000000 usd
CY2024Q1 hcsg Debt Instrument Covenant Number
DebtInstrumentCovenantNumber
2 covenant
CY2024Q1 hcsg Lineof Credit Facility Increase Decrease Remaining Borrowing Capacity
LineofCreditFacilityIncreaseDecreaseRemainingBorrowingCapacity
-72400000 usd
CY2024Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
187600000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000731012-24-000065-index-headers.html Edgar Link pending
0000731012-24-000065-index.html Edgar Link pending
0000731012-24-000065.txt Edgar Link pending
0000731012-24-000065-xbrl.zip Edgar Link pending
ex311section302certificati.htm Edgar Link pending
ex312section302certificati.htm Edgar Link pending
ex321section906certificati.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hcsg-20240331.htm Edgar Link pending
hcsg-20240331.xsd Edgar Link pending
hcsg-20240331_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
hcsg-20240331_cal.xml Edgar Link unprocessable
hcsg-20240331_def.xml Edgar Link unprocessable
hcsg-20240331_lab.xml Edgar Link unprocessable
hcsg-20240331_pre.xml Edgar Link unprocessable
hcsg-20240331_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable